Delgocitinib cream is effective and safe for the treatment of chronic hand eczema
1. More patients in the delgocitinib cream group reported clear or almost clear skin at week 16 in both the ...
Tag: dermatology
Long-term survival improved with use of tebentafusp for metastatic uveal melanoma
1. Across a median follow-up of 48.5 months, usage of tebentafusp for patients with metastatic uveal melanoma was associated with ...
Bimekizumab safe and effective for treatment of moderate-to-severe hidradenitis suppurative
1. Significantly more patients in the bimekizumab group than placebo reported improved clinical response at week 16. 2. Treatment-related adverse ...
Radiation treatment for breast cancer may increase incidence of nonkeratinocyte skin cancer
1. Amongst a cohort of breast cancer survivors, those that were treated with radiation had a higher risk of developing ...
#VisualAbstract: Interleukin-23 receptor antagonist improves psoriasis symptoms
1. In this randomized controlled trial, treatment with JNJ-77242113 improved psoriasis symptoms as compared to a placebo. 2. JNJ-77242113 showed ...
Interleukin-23 receptor antagonist improves psoriasis symptoms
1. In this randomized controlled trial, treatment with JNJ-77242113 improved psoriasis symptoms as compared to a placebo. 2. JNJ-77242113 showed ...
Spesolimab may improve quality of life in patients with generalized pustular psoriasis flares
1. Efficacy of spesolimab appeared to be dose-dependent with high-dose spesolimab leading to a significantly longer time to GPP flare-up ...
#VisualAbstract: Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma
1. Disease-free survival at 24 months was 84% in the nivolumab group compared to 73% in the observation group. 2. ...
Maggot debridement therapy effective for full-thickness burn treatment
1. The current randomized controlled trial is the first of its kind to demonstrate the efficacy of maggot debridement therapy ...
Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma
1. Disease-free survival at 24 months was 84% in the nivolumab group compared to 73% in the observation group. 2. ...
